Baseline characteristics

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 · Source last updated 2016-12-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      59

   units

   Participants

groups

1. description

   This was a follow-up safety study where study treatment was not administered. Patients came from BGG492 studies where patients were previously exposed to \> 28 days of BGG492 50 mg, 100 mg or 150 mg given orally three times a day

   id

   BG000

   title

   BGG492

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            11.58

            value

            43.2

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            31

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            28

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Gender

   unit Of Measure

   Participants

population Description

Includes all patients who signed the informed consent form for the study.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice